CROSS DEEP SURGERY
CROSS DEEP SURG & MED CTR, 4 CROSS DEEP, TWICKENHAM
Stroke 12
The % of patients with a stroke shown to be non-haemorrhagic, or a history of TIA, who have a record that an anti-platelet agent (aspirin, clopidogrel, dipyridamole or a combination), or an anti-coagulant is being taken (unless a contraindication or side-effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| STROKE 9 | 2005 | 39 | 40 | 97.5% | |
| STROKE 9 | 2006 | 40 | 43 | 93.0% | |
| Stroke 12 | 2007 | 49 | 49 | 100.0% | |
| Stroke 12 | 2008 | 48 | 52 | 92.3% | |
| Stroke 12 | 2009 | 51 | 53 | 96.2% | |
| Stroke 12 | 2010 | 52 | 54 | 96.3% | |
| STROKE 12 | 2011 | 62 | 68 | 91.2% | |
| STROKE 12 | 2012 | 69 | 76 | 90.8% | |
| STROKE 12 | 2013 | 73 | 81 | 90.1% | |
| STIA007 | 2014 | 74 | 76 | 97.4% | |
| STIA007 | 2015 | 74 | 76 | 97.4% | |
| STIA007 | 2016 | 72 | 73 | 98.6% | |
| STIA007 | 2017 | 75 | 75 | 100.0% | |
| STIA007 | 2018 | 74 | 74 | 100.0% | |
| STIA007 | 2019 | 77 | 78 | 98.7% | |
| STIA007 | 2020 | 84 | 84 | 100.0% | |
| STIA007 | 2021 | 79 | 95 | 83.2% | |
| STIA007 | 2022 | 100 | 100 | 100.0% | |
| STIA007 | 2023 | 114 | 116 | 98.3% |
